Bachour, F. A., Blankenship, J. C., Iliadis, E. A., Tasissa, G., O’Shea, J. C., Kitt, M. M., … Tcheng, J. E. (2001). Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutaneous coronary intervention in ESPRIT. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 37(2), 84A-84A.

Bachour, F. A., J. C. Blankenship, E. A. Iliadis, G. Tasissa, J. C. O’Shea, M. M. Kitt, T. J. Lorenz, and J. E. Tcheng. “Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutaneous coronary intervention in ESPRIT.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 1, 2001): 84A-84A.

Bachour FA, Blankenship JC, Iliadis EA, Tasissa G, O’Shea JC, Kitt MM, et al. Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutaneous coronary intervention in ESPRIT. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001 Feb 1;37(2):84A-84A.

Bachour, F. A., et al. “Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutaneous coronary intervention in ESPRIT.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 37, no. 2, ELSEVIER SCIENCE INC, Feb. 2001, pp. 84A-84A.

Bachour FA, Blankenship JC, Iliadis EA, Tasissa G, O’Shea JC, Kitt MM, Lorenz TJ, Tcheng JE. Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutaneous coronary intervention in ESPRIT. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2001 Feb 1;37(2):84A-84A.